Skip to content

Study on the Safety and Effectiveness of Robot Assisted Total Knee Arthroplasty under Supervised Mode

Study on the safety and effectiveness of robot-assisted total knee arthroplasty under supervised mode

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114541
Enrollment
Unknown
Registered
2025-12-15
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Experimental group:Experienced senior doctors plan surgeries, and middle-aged doctors perform robot assisted total knee arthroplasty under the supervision of senior doctors.
Control group:Planning and execution were carried out by the same experienced senior physician.

Sponsors

The Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (a) Male or female participants, aged 40-80 years (inclusive); (b) The subject is suitable for initial knee replacement surgery due to primary osteoarthritis, rheumatoid arthritis, traumatic arthritis, etc; (c) The subjects voluntarily and in writing agree to participate in the study and have signed an informed consent form approved by the ethics committee; (d) The subjects are able to understand the clinical study, cooperate with the research procedures, and are willing to return to the hospital for postoperative follow-up within 12 months according to the protocol.

Exclusion criteria

Exclusion criteria: (a) The subject is known or suspected to be allergic to metals; (b) It is known that the subject has insufficient bone mass in the femur or tibia due to diseases such as tumors, severe osteoporosis, metabolic bone disease, etc., which makes it impossible to support and/or fix the prosthesis; (c) The subject suffers from diseases that may endanger the stability of the implant or postoperative recovery (such as neuroarthritis, moderate to severe muscle dysfunction in the lower limb on the surgical side, etc.); (d) The subjects may have emotional problems or neurological conditions that may affect their ability or willingness to participate in the study (such as mental illness, mental retardation); (e) Pregnant or lactating women or women planning to become pregnant during the study period; (f) It is known that there is a risk of the subject being lost to follow-up or not returning to the hospital for follow-up according to regulations; (g) The subject has participated in clinical studies of other drugs, biologics, or devices within the past 12 months.

Design outcomes

Primary

MeasureTime frame
Clinical success rate;

Countries

China

Contacts

Public ContactZanjing Zhai

The Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

zanjing_zhai@163.com+86 136 5189 0615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026